Skip to main content

Profile

Loading content

Dr Bridget Watson

Research Fellow

 Environment and Sustainability Institute 

 

Environment and Sustainability Institute, University of Exeter, Penryn Campus, Penryn, Cornwall, TR10 9FE, UK

Overview

Research

Publications

Key publications | Publications by category | Publications by year

Publications by category


Journal articles

Watson BNJ, Vercoe RB, Salmond GPC, Westra ER, Staals RHJ, Fineran PC (In Press). Type I-F CRISPR-Cas resistance against virulent phage infection triggers abortive infection and provides population-level immunity.  Abstract.
Watson BNJ, Steens JA, Staals RHJ, Westra ER, van Houte S (2021). Coevolution between bacterial CRISPR-Cas systems and their bacteriophages. Cell Host Microbe, 29(5), 715-725. Abstract.  Author URL.  Full text.
Rollie C, Chevallereau A, Watson BNJ, Chyou T-Y, Fradet O, McLeod I, Fineran PC, Brown CM, Gandon S, Westra ER, et al (2020). Publisher Correction: Targeting of temperate phages drives loss of type I CRISPR-Cas systems. Nature, 579(7799). Abstract.  Author URL.
Rollie C, Chevallereau A, Watson BNJ, Chyou T-Y, Fradet O, McLeod I, Fineran PC, Brown CM, Gandon S, Westra ER, et al (2020). Targeting of temperate phages drives loss of type I CRISPR–Cas systems. Nature, 578(7793), 149-153. Full text.
Hampton HG, Watson BNJ, Fineran PC (2020). The arms race between bacteria and their phage foes. Nature, 577(7790), 327-336. Abstract.
Watson BNJ, Easingwood RA, Tong B, Wolf M, Salmond GPC, Staals RHJ, Bostina M, Fineran PC (2019). Different genetic and morphological outcomes for phages targeted by single or multiple CRISPR-Cas spacers. Philosophical Transactions of the Royal Society B Biological Sciences, 374(1772).
Watson BNJ, Vercoe RB, Salmond GPC, Westra ER, Staals RHJ, Fineran PC (2019). Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity. Nat Commun, 10(1). Abstract.  Author URL.  Full text.
Watson BNJ, Staals RHJ, Fineran PC (2018). CRISPR-Cas-Mediated Phage Resistance Enhances Horizontal Gene Transfer by Transduction. mBio, 9(1), e02406-e02417.
Pawluk A, Staals RHJ, Taylor C, Watson BNJ, Saha S, Fineran PC, Maxwell KL, Davidson AR (2016). Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species. Nature Microbiology, 1(8).
Richter C, Dy RL, McKenzie RE, Watson BNJ, Taylor C, Chang JT, McNeil MB, Staals RHJ, Fineran PC (2014). Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer. Nucleic Acids Research, 42(13), 8516-8526.
McNeil MB, Hampton HG, Hards KJ, Watson BNJ, Cook GM, Fineran PC (2013). The succinate dehydrogenase assembly factor, SdhE, is required for the flavinylation and activation of fumarate reductase in bacteria. FEBS Letters, 588(3), 414-421.

Publications by year


In Press

Watson BNJ, Vercoe RB, Salmond GPC, Westra ER, Staals RHJ, Fineran PC (In Press). Type I-F CRISPR-Cas resistance against virulent phage infection triggers abortive infection and provides population-level immunity.  Abstract.

2021

Watson BNJ, Steens JA, Staals RHJ, Westra ER, van Houte S (2021). Coevolution between bacterial CRISPR-Cas systems and their bacteriophages. Cell Host Microbe, 29(5), 715-725. Abstract.  Author URL.  Full text.

2020

Rollie C, Chevallereau A, Watson BNJ, Chyou T-Y, Fradet O, McLeod I, Fineran PC, Brown CM, Gandon S, Westra ER, et al (2020). Publisher Correction: Targeting of temperate phages drives loss of type I CRISPR-Cas systems. Nature, 579(7799). Abstract.  Author URL.
Rollie C, Chevallereau A, Watson BNJ, Chyou T-Y, Fradet O, McLeod I, Fineran PC, Brown CM, Gandon S, Westra ER, et al (2020). Targeting of temperate phages drives loss of type I CRISPR–Cas systems. Nature, 578(7793), 149-153. Full text.
Hampton HG, Watson BNJ, Fineran PC (2020). The arms race between bacteria and their phage foes. Nature, 577(7790), 327-336. Abstract.

2019

Watson BNJ, Easingwood RA, Tong B, Wolf M, Salmond GPC, Staals RHJ, Bostina M, Fineran PC (2019). Different genetic and morphological outcomes for phages targeted by single or multiple CRISPR-Cas spacers. Philosophical Transactions of the Royal Society B Biological Sciences, 374(1772).
Watson BNJ, Vercoe RB, Salmond GPC, Westra ER, Staals RHJ, Fineran PC (2019). Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity. Nat Commun, 10(1). Abstract.  Author URL.  Full text.

2018

Watson BNJ, Staals RHJ, Fineran PC (2018). CRISPR-Cas-Mediated Phage Resistance Enhances Horizontal Gene Transfer by Transduction. mBio, 9(1), e02406-e02417.

2016

Pawluk A, Staals RHJ, Taylor C, Watson BNJ, Saha S, Fineran PC, Maxwell KL, Davidson AR (2016). Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species. Nature Microbiology, 1(8).

2014

Richter C, Dy RL, McKenzie RE, Watson BNJ, Taylor C, Chang JT, McNeil MB, Staals RHJ, Fineran PC (2014). Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer. Nucleic Acids Research, 42(13), 8516-8526.

2013

McNeil MB, Hampton HG, Hards KJ, Watson BNJ, Cook GM, Fineran PC (2013). The succinate dehydrogenase assembly factor, SdhE, is required for the flavinylation and activation of fumarate reductase in bacteria. FEBS Letters, 588(3), 414-421.

Bridget_Watson Details from cache as at 2022-07-02 04:34:02

Refresh publications

Teaching

Supervision / Group

Back | Edit Profile